- 50+ clinical sites in Poland, Bulgaria, Romania, Germany
- 50+ investigators in dermatology
- Therapeutic equivalence trials
- Pharmacokinetic trials
Glaucoma
- phase III trial in 250 patients
Conjunctivitis
- phase III trial in 120 patients
Allergic and viral rhinitis
- two phase III trials